Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI

被引:59
|
作者
Redfors, Bjorn [1 ,2 ,3 ]
Furer, Ariel [1 ,4 ,5 ]
Selker, Harry P. [6 ]
Thiele, Holger [7 ,8 ]
Patel, Manesh R. [9 ]
Chen, Shmuel [1 ,2 ]
Udelson, James E. [10 ]
Ohman, E. Magnus [9 ]
Eitel, Ingo [11 ,12 ]
Granger, Christopher B. [9 ]
Maehara, Akiko [1 ,2 ]
Kirtane, Ajay J. [1 ,2 ]
Genereux, Philippe [1 ,13 ,14 ]
Jenkins, Paul L. [15 ]
Ben-Yehuda, Ori [1 ,2 ]
Stone, Gregg W. [1 ,16 ]
机构
[1] Cardiovasc Res Fdn, Clin Trials Ctr, New York, NY USA
[2] Columbia Univ, Med Ctr, Dept Cardiol, NewYork Presbyterian Hosp, New York, NY USA
[3] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden
[4] Israel Def Forces, Med Corps, Tel Hashomer, Israel
[5] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mil Med, Jerusalem, Israel
[6] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA
[7] Univ Leipzig, Heart Ctr Leipzig, Leipzig, Germany
[8] Leipzig Heart Inst, Leipzig, Germany
[9] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA
[10] Tufts Med Ctr, Div Cardiol, Boston, MA 02111 USA
[11] Univ Heart Ctr Lubeck, Univ Hosp Schleswig Holstein, Med Clin Cardiol Angiol Intens Care Med 2, Lubeck, Germany
[12] German Ctr Cardiovasc Res DZHK, Partner Site Hamburg Kiel Lubeck, Lubeck, Germany
[13] Morristown Med Ctr, Gagnon Cardiovasc Inst, Morristown, NJ USA
[14] Hop Sacre Coeur Montreal, Montreal, PQ, Canada
[15] Mary Imogene Bassett Hosp, Cooperstown, NY USA
[16] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA
基金
美国国家卫生研究院;
关键词
infarct size; percutaneous coronary intervention (PCI); smoking; ST-segment elevation myocardial infarction (STEMI); ACUTE MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; RECEIVING THROMBOLYTIC THERAPY; BOLUS ABCIXIMAB APPLICATION; SMOKERS PARADOX; CIGARETTE-SMOKING; POOLED ANALYSIS; GUSTO-I; SIZE; TRIAL;
D O I
10.1016/j.jacc.2020.02.045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Smoking is a well-established risk factor for ST-segment elevation myocardial infarction (STEMI); however, once STEMI occurs, smoking has been associated with favorable short-term outcomes, an observation termed the "smoker's paradox." It has been postulated that smoking might exert protective effects that could reduce infarct size, a strong independent predictor of worse outcomes after STEMI. OBJECTIVES The purpose of this study was to determine the relationship among smoking, infarct size, microvascular obstruction (MVO), and adverse outcomes after STEMI. METHODS Individual patient-data were pooled from 10 randomized trials of patients with STEMI undergoing primary percutaneous coronary intervention. Infarct size was assessed at median 4 days by either cardiac magnetic resonance imaging or technetium-99m sestamibi single-photon emission computed tomography. Multivariable analysis was used to assess the relationship between smoking, infarct size, and the 1-year rates of death or heart failure (HF) hospitalization and reinfarction. RESULTS Among 2,564 patients with STEMI, 1,093 (42.6%) were recent smokers. Smokers were 10 years younger and had fewer comorbidities. Infarct size was similar in smokers and nonsmokers (adjusted difference: 0.0%; 95% confidence interval [CI]: -3.3% to 3.3%; p = 0.99). Nor was the extent of MVO different between smokers and nonsmokers. Smokers had lower crude 1-year rates of all-cause death (1.0% vs. 2.9%; p < 0.001) and death or HF hospitalization (3.3% vs. 5.1%; p = 0.009) with similar rates of reinfarction. After adjustment for age and other risk factors, smokers had a similar 1-year risk of death (adjusted hazard ratio [adjHR]: 0.92; 95% CI: 0.46 to 1.84) and higher risks of death or HF hospitalization (adjHR: 1.49; 95% CI: 1.09 to 2.02) as well as reinfarction (adjHR: 1.97; 95% CI: 1.17 to 3.33). CONCLUSIONS In the present large-scale individual patient-data pooled analysis, recent smoking was unrelated to infarct size or MVO, but was associated with a worse prognosis after primary PCI in STEMI. The smoker's paradox may be explained by the younger age and fewer cardiovascular risk factors in smokers compared with nonsmokers. (C) 2020 by the American College of Cardiology Foundation.
引用
收藏
页码:1743 / 1754
页数:12
相关论文
共 50 条
  • [31] TRENDS IN DOOR-TO-BALLOON TIME AND OUTCOMES FOLLOWING PRIMARY PCI FOR STEMI
    Brennan, Angela L.
    Andrianopoulos, Nick
    Duffy, Stephen
    Ajani, Andrew E.
    Clark, David
    Lefkovits, Jeffrey
    Black, Alexander
    Brooks, Matthew
    Yan, Bryan
    New, Gishel
    Loane, Philippa
    Roberts, Louise
    Reid, Christopher
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E148 - E148
  • [32] The Effect of Primary PCI of Culprit Artery on Epicardial Flow in Nonculprit Artery in Patients with Anterior STEMI
    Yan, Hongbing
    Wang, Jian
    Zheng, Bin
    Chi, Yunpeng
    Wu, Zheng
    Zhao, Yong
    Zhang, Xiaojiang
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (8A): : 37A - 37A
  • [33] An aggressive pharmacoinvasive strategy for STEMI may deliver comparable outcomes to primary PCI
    Adlam, D.
    Ehtisham, J.
    Mckenna, C. J.
    Spyrou, N.
    Swinburn, J. M.
    Orr, W. P.
    EUROPEAN HEART JOURNAL, 2008, 29 : 516 - 516
  • [34] Regression of Q waves and clinical outcomes following primary PCI in anterior STEMI
    de Framond, Yuni
    Schaaf, Mathieu
    Pichot-Lamoureux, Sophie
    Range, Gregoire
    Dubreuil, Olivier
    Angoulvant, Denis
    Claeys, Marc J.
    Dorado, David Garcia
    Bochaton, Thomas
    Rioufol, Gilles
    Jossan, Claire
    Boussaha, Inesse
    Ovize, Michel
    Mewton, Nathan
    JOURNAL OF ELECTROCARDIOLOGY, 2022, 73 : 131 - 136
  • [35] Clinical Outcomes of Patients with Alcoholic Cirrhosis and Acute STEMI Undergoing PCI
    Alwarawrah, Zaid
    Alziadin, Nmair
    Alhalaseh, Saleh
    Odac, Barbara
    El Sharu, Husam
    Al, Omar
    CIRCULATION, 2024, 150
  • [36] PREDICTORS OF NO-REFLOW PHENOMENON DURING PRIMARY PCI IN STEMI PATIENTS
    Seong, Myungjun M., Jr.
    Kim, Kee Sik
    Kim, Byong-kyu
    Son, Ja-young
    Hong, Seung-pyo
    Lee, Young Soo
    Lee, Jin Bae
    Ryu, Jae Kean
    Choi, Ji Young
    Chang, Sung-Gug
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E942 - E942
  • [37] EARLY ANTIPLATELET THERAPY UPGRADE IN STEMI PATIENTS TREATED WITH PRIMARY PCI
    Lupi, A.
    Lazzero, M.
    Rognoni, A.
    Cavallino, C.
    Bongo, A. S.
    CARDIOLOGY, 2016, 134 : 47 - 47
  • [38] Early antiplatelet therapy upgrade in STEMI patients treated with primary PCI
    Lupi, A.
    Rognoni, A.
    Rossi, L.
    Cavallino, C.
    Rosso, R.
    Lazzero, M.
    Bongo, A. S.
    Porto, I.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1384 - 1384
  • [39] Platelets reactivity as a predictor of the extent of myocardial infarct damage and poor outcomes in STEMI patients undergoing primary PCI
    Massalha, E.
    Goitein, O.
    Fardman, A.
    Grupper, A.
    Mazin, I
    Natanzon, S.
    Beigel, R.
    Matetsky, S.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1550 - 1550
  • [40] Sex-related differences in STEMI patients treated by primary PCI
    Barthelemy, O.
    Degrell, P.
    Petroni, T.
    Silvain, J.
    Choussat, R.
    Collet, J. P.
    Helft, G.
    Michel, P. L.
    Montalescot, G.
    Le Feuvre, C.
    EUROPEAN HEART JOURNAL, 2013, 34 : 237 - 237